daytrading jan 2 pre-market, page-9

think AZY will be good for a qtr or 2

by all indications they'll be nothing spectacular in first round assays for Calibre [similar low grade to magnum?], but the untested higher EM response at depth [suggesting better grades] I think is what will keep interest in the stock. given Calibre is the focus for 2013 hopefully anticipation builds and builds into phase two results [maybe late q1]. At $9-10m lots of room for healthy anticipation